Up a level |
Shen, Fei; Jiang, Guanglong; Philips, Santosh; Cantor, Erica; Gardner, Laura; Xue, Gloria; Cunningham, Geneva; Kassem, Nawal; O'Neill, Anne; Cameron, David; Suter, Thomas M; Miller, Kathy D; Sledge, George W; Schneider, Bryan P (2024). Germline predictors for bevacizumab induced hypertensive crisis in ECOG-ACRIN 5103 and BEATRICE. British journal of cancer, 130(8), pp. 1348-1355. Nature Publishing Group 10.1038/s41416-024-02602-0
Demirel, Caglayan; Tomii, Daijiro; Heg, Dik; Okuno, Taishi; Wieser, Fabian; Suter, Thomas M; Gräni, Christoph; Windecker, Stephan; Pilgrim, Thomas (2023). Incidental detection of malignancy during pre-procedural workup for transcatheter aortic valve implantation: a longitudinal cohort study. American Heart Journal, 261, pp. 51-54. Elsevier 10.1016/j.ahj.2023.03.011
Schneider, Caroline; Ryffel, Christoph; Stütz, Laura; Rabaglio, Manuela; Suter, Thomas M; Campbell, Kristin L; Eser, Prisca; Wilhelm, Matthias (2023). Supervised exercise training in patients with cancer during anthracycline-based chemotherapy to mitigate cardiotoxicity: a randomized-controlled-trial. Frontiers in cardiovascular medicine, 10(1283153), p. 1283153. Frontiers 10.3389/fcvm.2023.1283153
Lyon, Alexander R; López-Fernández, Teresa; Couch, Liam S; Asteggiano, Riccardo; Aznar, Marianne C; Bergler-Klein, Jutta; Boriani, Giuseppe; Cardinale, Daniela; Cordoba, Raul; Cosyns, Bernard; Cutter, David J; de Azambuja, Evandro; de Boer, Rudolf A; Dent, Susan F; Farmakis, Dimitrios; Gevaert, Sofie A; Gorog, Diana A; Herrmann, Joerg; Lenihan, Daniel; Moslehi, Javid; ... (2022). 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). European heart journal, 43(41), pp. 4229-4361. Oxford University Press 10.1093/eurheartj/ehac244
Schindera, Christina; Kuehni, Claudia Elisabeth; Pavlovic, Mladen; Haegler-Laube, Eva; Rhyner, Daniel; Waespe, Nicolas; Roessler, Jochen; Suter, Thomas M; von der Weid, Nicolas Xavier (2020). Diagnosing Preclinical Cardiac Dysfunction in Swiss ChildhoodCancer Survivors: Protocol for a Single-Center Cohort Study. JMIR research protocols, 9(6), e17724. JMIR Publications 10.2196/17724
Zuppinger, Christian; Gibbons, George; Dutta-Passecker, Priyanka; Segiser, Adrian; Most, Henriette; Suter, Thomas M (2017). Characterization of cytoskeleton features and maturation status of cultured human iPSC-derived cardiomyocytes. European journal of histochemistry, 61(2), p. 2763. PAGEPress 10.4081/ejh.2017.2763
Chiusa, Manuel; Hool, Sara-Lynn; Truetsch, Petra; Djafarzadeh, Siamak; Jakob, Stephan M; Seifriz, Franziska; Scherer, Stefan J; Suter, Thomas M; Zuppinger, Christian; Zbinden, Stephan (2012). Cancer therapy modulates VEGF signaling and viability in adult rat cardiac microvascular endothelial cells and cardiomyocytes. Journal of molecular and cellular cardiology, 52(5), pp. 1164-75. Oxford: Elsevier 10.1016/j.yjmcc.2012.01.022
Dimitrakis, Polychronis; Romay-Ogando, Maria-Iris; Timolati, Francesco; Suter, Thomas M; Zuppinger, Christian (2012). Effects of doxorubicin cancer therapy on autophagy and the ubiquitin-proteasome system in long-term cultured adult rat cardiomyocytes. Cell and tissue research, 350(2), pp. 361-72. Heidelberg: Springer-Verlag 10.1007/s00441-012-1475-8
Stortecky, Stefan; Suter, Thomas M (2010). Insights into cardiovascular side-effects of modern anticancer therapeutics. Current opinion in oncology, 22(4), pp. 312-7. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/CCO.0b013e32833ab6f1
Zuppinger, Christian; Suter, Thomas M (2010). Cancer therapy-associated cardiotoxicity and signaling in the myocardium. Journal of cardiovascular pharmacology, 56(2), pp. 141-6. Hagerstown, Md.: Wolters Kluwer Lippincott Williams & Wilkins 10.1097/FJC.0b013e3181e0f89a
Procter, Marion; Suter, Thomas M; de Azambuja, Evandro; Dafni, Urania; van Dooren, Veerle; Muehlbauer, Susanne; Climent, Miguel Angel; Rechberger, Ernst; Liu, Walter Tsang-Wu; Toi, Mazakasu; Coombes, R Charles; Dodwell, David; Pagani, Olivia; Madrid, Jorge; Hall, Marcia; Chen, Shin-Cheh; Focan, Christian; Muschol, Michael; van Veldhuisen, Dirk J and Piccart-Gebhart, Martine J (2010). Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial. Journal of clinical oncology, 28(21), pp. 3422-8. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2009.26.0463
Timolati, Francesco; Anliker, Tobias; Groppalli, Vittoria; Perriard, Jean-Claude; Eppenberger, Hans M; Suter, Thomas M; Zuppinger, Christian (2009). The role of cell death and myofibrillar damage in contractile dysfunction of long-term cultured adult cardiomyocytes exposed to doxorubicin. Cytotechnology, 61(1-2), pp. 25-36. Dordrecht: Springer Netherlands 10.1007/s10616-009-9238-4
Pentassuglia, Laura; Graf, Michael; Lane, Heidi; Kuramochi, Yukio; Cote, Gregory; Timolati, Francesco; Sawyer, Douglas B; Zuppinger, Christian; Suter, Thomas M (2009). Inhibition of ErbB2 by receptor tyrosine kinase inhibitors causes myofibrillar structural damage without cell death in adult rat cardiomyocytes. Experimental cell research, 315(7), pp. 1302-12. San Diego, Calif.: Elsevier 10.1016/j.yexcr.2009.02.001
Pentassuglia, Laura; Timolati, Francesco; Seifriz, Franziska; Abudukadier, Kaisaier; Suter, Thomas M; Zuppinger, Christian (2007). Inhibition of ErbB2/neuregulin signaling augments paclitaxel-induced cardiotoxicity in adult ventricular myocytes. Experimental cell research, 313(8), pp. 1588-601. San Diego, Calif.: Elsevier 10.1016/j.yexcr.2007.02.007
Zuppinger, Christian; Timolati, Francesco; Suter, Thomas M (2007). Pathophysiology and diagnosis of cancer drug induced cardiomyopathy. Cardiovascular toxicology, 7(2), pp. 61-6. New York, N.Y.: Humana Press Inc 10.1007/s12012-007-0016-2
Suter, Thomas M; Procter, Marion; van Veldhuisen, Dirk J; Muscholl, Michael; Bergh, Jonas; Carlomagno, Chiara; Perren, Timothy; Passalacqua, Rodolfo; Bighin, Claudia; Klijn, Jan G M; Ageev, Fail T; Hitre, Erika; Groetz, Juergen; Iwata, Hiroji; Knap, Malgorzata; Gnant, Michael; Muehlbauer, Susanne; Spence, Alison; Gelber, Richard D and Piccart-Gebhart, Martine J (2007). Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial. Journal of clinical oncology, 25(25), pp. 3859-65. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2006.09.1611
Timolati, Francesco; Ott, Daniel; Pentassuglia, Laura; Giraud, Marie-Noëlle; Perriard, Jean-Claude; Suter, Thomas M; Zuppinger, Christian (2006). Neuregulin-1 beta attenuates doxorubicin-induced alterations of excitation-contraction coupling and reduces oxidative stress in adult rat cardiomyocytes. Journal of molecular and cellular cardiology, 41(5), pp. 845-54. Oxford: Elsevier 10.1016/j.yjmcc.2006.08.002
Kuster, Gabriela M; Tanner, Hildegard; Printzen, Gert; Suter, Thomas M; Mohacsi, Paul; Hess, Otto M (2002). B-type natriuretic peptide for diagnosis and treatment of congestive heart failure. Swiss medical weekly, 132(43-44), pp. 623-8. EMH Schweizerischer Ärzteverlag